These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 28098432)
1. A Multi-Mitochondrial Anticancer Agent that Selectively Kills Cancer Cells and Overcomes Drug Resistance. Peng YB; Zhao ZL; Liu T; Xie GJ; Jin C; Deng TG; Sun Y; Li X; Hu XX; Zhang XB; Ye M; Tan WH ChemMedChem; 2017 Feb; 12(3):250-256. PubMed ID: 28098432 [TBL] [Abstract][Full Text] [Related]
2. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers. Millard M; Gallagher JD; Olenyuk BZ; Neamati N J Med Chem; 2013 Nov; 56(22):9170-9. PubMed ID: 24147900 [TBL] [Abstract][Full Text] [Related]
3. Rerouting chlorambucil to mitochondria combats drug deactivation and resistance in cancer cells. Fonseca SB; Pereira MP; Mourtada R; Gronda M; Horton KL; Hurren R; Minden MD; Schimmer AD; Kelley SO Chem Biol; 2011 Apr; 18(4):445-53. PubMed ID: 21513881 [TBL] [Abstract][Full Text] [Related]
4. Structural modifications of mitochondria-targeted chlorambucil alter cell death mechanism but preserve MDR evasion. Jean SR; Pereira MP; Kelley SO Mol Pharm; 2014 Aug; 11(8):2675-82. PubMed ID: 24922525 [TBL] [Abstract][Full Text] [Related]
5. A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer. Pathak RK; Wen R; Kolishetti N; Dhar S Mol Cancer Ther; 2017 Apr; 16(4):625-636. PubMed ID: 28148716 [TBL] [Abstract][Full Text] [Related]
6. Targeted combinational therapy inducing mitochondrial dysfunction. Shin WS; Park SK; Verwilst P; Koo S; Lee JH; Chi SG; Kim JS Chem Commun (Camb); 2017 Jan; 53(7):1281-1284. PubMed ID: 28067351 [TBL] [Abstract][Full Text] [Related]
7. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways. Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681 [TBL] [Abstract][Full Text] [Related]
8. A novel manganese complex LMnAc selectively kills cancer cells by induction of ROS-triggered and mitochondrial-mediated cell death. Li X; Zhao K; Guo W; Liu X; Liu J; Gao J; Chen Q; Bai Y Sci China Life Sci; 2014 Oct; 57(10):998-1010. PubMed ID: 24935782 [TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics. Hu Q; Gao M; Feng G; Liu B Angew Chem Int Ed Engl; 2014 Dec; 53(51):14225-9. PubMed ID: 25318447 [TBL] [Abstract][Full Text] [Related]
10. Mitochondria determine the efficacy of anticancer agents that interact with DNA but not the cytoskeleton. Hara K; Kasahara E; Takahashi N; Konishi M; Inoue J; Jikumaru M; Kubo S; Okamura H; Sato E; Inoue M J Pharmacol Exp Ther; 2011 Jun; 337(3):838-45. PubMed ID: 21421738 [TBL] [Abstract][Full Text] [Related]
11. The Involvement of Mitochondrial Membrane Potential in Cross-Resistance Between Radiation and Docetaxel. Kuwahara Y; Roudkenar MH; Suzuki M; Urushihara Y; Fukumoto M; Saito Y; Fukumoto M Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):556-65. PubMed ID: 27681752 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance. Skildum A; Dornfeld K; Wallace K Breast Cancer Res Treat; 2011 Oct; 129(3):785-97. PubMed ID: 21128112 [TBL] [Abstract][Full Text] [Related]
13. Three-Arm, Biotin-Tagged Carbazole-Dicyanovinyl-Chlorambucil Conjugate: Simultaneous Tumor Targeting, Sensing, and Photoresponsive Anticancer Drug Delivery. Venkatesh Y; Karthik S; Rajesh Y; Mandal M; Jana A; Singh ND Chem Asian J; 2016 Dec; 11(24):3482-3486. PubMed ID: 27706928 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway. Li H; Jiao S; Li X; Banu H; Hamal S; Wang X Can J Physiol Pharmacol; 2017 Jan; 95(1):43-50. PubMed ID: 27831748 [TBL] [Abstract][Full Text] [Related]
15. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Roh JL; Park JY; Kim EH; Jang HJ; Kwon M Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells. Arancia G; Calcabrini A; Marra M; Crateri P; Artico M; Martone A; Martelli F; Agostinelli E Amino Acids; 2004 Jun; 26(3):273-82. PubMed ID: 15221508 [TBL] [Abstract][Full Text] [Related]
17. Molecular features of the cytotoxicity of an NHE inhibitor: Evidence of mitochondrial alterations, ROS overproduction and DNA damage. Aredia F; Czaplinski S; Fulda S; Scovassi AI BMC Cancer; 2016 Nov; 16(1):851. PubMed ID: 27816051 [TBL] [Abstract][Full Text] [Related]
18. Hoechst 33342 induces radiosensitization in malignant glioma cells via increase in mitochondrial reactive oxygen species. Athar M; Chaudhury NK; Hussain ME; Varshney R Free Radic Res; 2010 Aug; 44(8):936-49. PubMed ID: 20540663 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of Tetraarylethylene-based Mono-, Bis-, and Tris(pyridinium) Derivatives for Image-Guided Mitochondria-Specific Targeting and Cytotoxicity of Metastatic Melanoma Cells. Reedy JL; Hedlund DK; Gabr MT; Henning GM; Pigge FC; Schultz MK Bioconjug Chem; 2016 Oct; 27(10):2424-2430. PubMed ID: 27643916 [TBL] [Abstract][Full Text] [Related]
20. Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism. Mourtada R; Fonseca SB; Wisnovsky SP; Pereira MP; Wang X; Hurren R; Parfitt J; Larsen L; Smith RA; Murphy MP; Schimmer AD; Kelley SO PLoS One; 2013; 8(4):e60253. PubMed ID: 23585833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]